Journal of Dermatologic Research And Therapy

ISSN: 2471-2175

JDRT

Ongoing Special Issue
 
Special Issue On -   Current trends in melanoma research
 
Special issue By Anand Rotte
 
This special issue calls for original papers with important and novel contributions related to – “Melanoma, epigenetics and cancer immunotherapy”
 

Topics of interests include

  • Melanoma
  • Etiology
  • Prognosis
  • DNA repair
  • ROS
  • UV radiation
  • epigenetics
  • BRAFV600E
  • MAPK
  • MEK
  • CTLA-4
  • PD-1
  • oncolytic viruses
  • cancer vaccines
  • CAR-T cells
  • Update on melanoma etiology and treatment
  • Changes in melanoma treatment after approval of checkpoint blockers
  • Recent advances in treatment of metastatic melanoma

We look for high quality publications on - "Current trends in melanoma research".

Reviews which include the comparative view, Original research papers as well as short communications and letters on new developments and applications are welcome and are to be written in Standard English. Formatting of manuscript with headings and Sub headings is necessary and views are to be presented clearly. New approaches are mainly in interest.


Metrics:

  • Last Date of Submissions: Will be updated soon
  • Acceptance period:
    • 1st round – 1 month
    • 2nd round – 3 weeks
    • 3rd round – 2 weeks
    • 4th round – 1 week
  • Last Date of Publication: Will be updated soon
  • People involved: Dr. Anand Rotte - Editor

 

Dr. Anand Rotte

Editor

 


The importance and need for this special issue:

The emerging challenges and solutions provided by Modern methods are extremely interesting and are of great hope for the future.  This platform brings forth the outstanding research information in the specified field which helps researchers to have a perfect source specifically designed for research on "Melanoma, epigenetics and cancer immunotherapy" with much emphasis on immunity and cure

This resource not only affects the way the trending research is evolving, but also creates tremendous new support for the now working researchers to put forth their work at a worthy and specifically targeted readership for the desired proper usage of the knowledge dissipated by you.

This research area has many new challenges in the future and many challenges still remain to be resolved, and we hope that this issue will help to open new horizons for research on Melanoma, epigenetics and cancer immunotherapy.